Evidence map›Paper›PMID 32025750›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2020

Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse.

Antoine Leimgruber, Kevin Hickson, Sze Ting Lee, Hui K Gan, Lawrence M Cher, John I Sachinidis, Graeme J O'Keefe, Andrew M Scott

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Multilevel Mechanisms of Cancer Drug Resistance.International journal of molecular sciences · 2024
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The application ofQuantitative imaging in medicine and surgery · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Galectin expression detected byEuropean journal of nuclear medicine and molecular imaging · 2022
    Article
  15. Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI,Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Antoine LeimgruberDepartment of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.
Kevin HicksonDepartment of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.
Sze Ting LeeDepartment of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.
Hui K GanService of Medical Imaging, Hospital Riviera Chablais, Rennaz, Switzerland.
Lawrence M CherDepartment of Medicine, The University of Melbourne, Austin Health, PO Box 5555, Heidelberg, Vic, 3084, Australia.
John I SachinidisDepartment of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.
Graeme J O'KeefeDepartment of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.
Andrew M ScottDepartment of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia. andrew.scott@onjcri.org.au.ORCID 0000-0002-6656-295X
Austin Health · AULa Trobe University · AUHôpital Riviera-Chablais · CHThe University of Melbourne · AU

Funding

Department of Health and Human Services, State Government of Victoria CRE in Brain CancerNational Health and Medical Research Council 1084178National Health and Medical Research Council 1092788
6 · The paper itself

Abstract

introductionTumor hypoxia is a centerpiece of disease progression mechanisms such as neoangiogenesis or aggressive hypoxia-resistant malignant cells selection that impacts on radiotherapy strategies. Early identification of regions at risk for recurrence and prognostic-based classification of patients is a necessity to devise tailored therapeutic strategies. We developed an image-based algorithm to spatially map areas of aerobic and anaerobic glycolysis (Glyoxia).

methods

resultsIn the 10 glioblastoma patients (5M:5F; age range 51-69 years), 14/18

conclusionSpatial mapping of aerobic and anaerobic glycolysis allows unique information on tumor metabolism and hypoxia to be evaluated with PET, providing a greater understanding of tumor biology and potential response to therapy.

Indexed as

GlioblastomaAgedFluorodeoxyglucose F18GlycolysisHumansHypoxiaMiddle AgedMisonidazoleNeoplasm Recurrence, LocalPositron-Emission TomographyProspective StudiesRadiopharmaceuticalsFluorodeoxyglucose F18MisonidazoleRadiopharmaceuticals18F-FDG18F-FMISO PETGlioblastomaGlyoxiaHypoxia

Identifiers

PMID32025750
OpenAlexW3005187219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.